Addus HomeCare Corporation is projected to rise to $103.60 by 2027, a +10% move from its current price of $94.02. ADUS is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $92.80 | $94.06 | $95.34 | +0.05% |
| May 30 | $92.33 | $94.11 | $95.92 | +0.09% |
| May 31 | $91.97 | $94.15 | $96.38 | +0.14% |
| Jun 1 | $91.68 | $94.19 | $96.77 | +0.18% |
| Jun 2 | $91.43 | $94.23 | $97.12 | +0.23% |
| Jun 3 | $91.21 | $94.28 | $97.45 | +0.27% |
| Jun 4 | $91.01 | $94.32 | $97.75 | +0.32% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $91.01 | $94.32 | $97.75 | +0.32% |
| Week 2 | $89.96 | $94.62 | $99.53 | +0.64% |
| Week 3 | $89.23 | $94.93 | $100.98 | +0.96% |
| Week 4 | $88.66 | $95.23 | $102.28 | +1.29% |
| Week 5 | $88.20 | $95.53 | $103.48 | +1.61% |
| Week 6 | $87.81 | $95.84 | $104.60 | +1.94% |
| Week 7 | $87.48 | $96.15 | $105.68 | +2.26% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. Its Personal Care segment provides non-medical assistance with activities of daily living.
This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. Its Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization.
The company serves federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is based in Frisco, Texas.
The company serves federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is based in Frisco, Texas.
Addus HomeCare Corporation (ADUS) is a healthcare company trading with a current price of $92.65 and a market capitalization of $1.73B. It is currently ranked 2114 by market capitalization and overall market placement.
The near-term outlook shows the 2026 forecast with an average price of $92.65, a low of $90.98 and a high of $125.14, with a neutral sentiment and ROI of 0%.
In the longer horizon, the model projects a bullish trajectory: by 2030 the average price is $142.15 with a 53.4% ROI, by 2040 $309.81 average with 234.4% ROI, and by 2050 $602.24 average with 550% ROI, indicating a strong long-term upside in the forecast.
A major floor 8.6% below — a decisive break under it would weaken the trend.
The nearest floor, 3.2% below — buyers have tended to step in here.
The nearest ceiling, 6.5% above — a clean break opens room to run.
A major ceiling 25.1% above — clearing it would confirm fresh momentum.
Key ADUS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ADUS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $93.37 | Buy | $93.43 | Buy |
| MA 10 | $93.00 | Buy | $93.80 | Buy |
| MA 20 | $95.59 | Sell | $94.60 | Sell |
| MA 50 | $95.58 | Sell | $96.79 | Sell |
| MA 100 | $101.63 | Sell | $100.55 | Sell |
| MA 200 | $108.06 | Sell | $104.87 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 46.79 | Neutral |
| Stoch RSI (14) | 49.23 | Neutral |
| CCI (20) | -40.39 | Neutral |
| Williams %R (14) | -64.61 | Info |
| MACD (12,26,9) | -0.18 | Sell |
| ROC (12) | -5.57 | Sell |
| Bollinger %B (20,2) | 0.36 | Neutral |
| Stochastic %K (14) | 35.39 | Neutral |
| TRIX (15) | -0.10 | Sell |
| Awesome (5,34) | -1.72 | Sell |
| Ultimate (7,14,28) | 64.29 | Neutral |
| Momentum (10) | -4.47 | Sell |
| Aroon Osc (25) | -36.00 | Sell |
| Hull MA (9) | 93.46 | Buy |
| ADX (14) | 14.36 | Neutral |
| ATR (14) | 1.23 | Info |
The 30-day technical picture shows bearish sentiment overall. The RSI(14) is 40, and the 50-day simple moving average is $95.89 while the 200-day simple moving average is $108.22.
Prices have traded within a 30-day range from $84.39 to $101.72. Immediate support is at $90.98 and resistance at $100.12, suggesting near-term pressure with potential for a move toward the upper range if buyers gain momentum.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $90.98 | $94.02 | $127.59 | 0% | Neutral | |
| $84.63 | $103.60 | $132.74 | +10% | Neutral | |
| $93.34 | $116.35 | $152.97 | +24% | Bullish | |
| $101.76 | $128.76 | $172.81 | +37% | Bullish | |
| $113.27 | $145.23 | $198.37 | +54% | Bullish | |
| $133.79 | $173.62 | $240.84 | +85% | Bullish | |
| $137.77 | $180.78 | $254.30 | +92% | Bullish | |
| $143.15 | $189.81 | $270.42 | +102% | Bullish | |
| $154.40 | $206.74 | $298.03 | +120% | Bullish | |
| $148.96 | $201.34 | $293.45 | +114% | Bullish | |
| $226.80 | $319.67 | $488.11 | +240% | Bullish | |
| $415.24 | $627.59 | $1,026.91 | +568% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $90.98 | $94.02 | $109.76 | +0.00% |
| June 2026 | $80.87 | $94.34 | $112.18 | +0.34% |
| July 2026 | $83.54 | $98.02 | $117.66 | +3.90% |
| August 2026 | $84.59 | $99.69 | $120.54 | +1.71% |
| September 2026 | $84.23 | $99.64 | $121.20 | -0.05% |
| October 2026 | $86.14 | $102.25 | $125.04 | +2.61% |
| November 2026 | $88.00 | $104.77 | $128.73 | +2.47% |
| December 2026 | $86.59 | $103.38 | $127.59 | -1.32% |
Click any year to see its month-by-month ADUS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, ADUS could reach as high as $127.59, with a base case around $94.02 and support toward $90.98 — roughly 0% from $94.02. Price action looks broadly range-bound.
Expect ADUS to range from $84.63 to $132.74 through 2027. The $103.60 average target implies a +10% move from current prices. That is up +10% on the projected 2026 average. A consolidation phase looks the most probable path here.
The ADUS price prediction for 2028 points to an average of $116.35 (low $93.34, high $152.97) — a potential gain of +24% on today's $94.02. Momentum favours further upside here.
In 2029, ADUS is projected to trade between $101.76 and $172.81, averaging $128.76 — a potential gain of +37% from today's $94.02. That is up +11% on the projected 2028 average. Buyers look set to stay in control over this stretch.
Addus HomeCare Corporation's 2030 outlook centres on $145.23, within a $113.27 to $198.37 range. That is up +13% on the projected 2029 average. That marks a +54% change versus current levels. Momentum favours further upside here.
By 2031, ADUS could reach as high as $240.84, with a base case around $173.62 and support toward $133.79 — roughly +85% from $94.02. Buyers look set to stay in control over this stretch.
Expect ADUS to range from $137.77 to $254.30 through 2032. The $180.78 average target implies a +92% move from current prices. That is up +4% on the projected 2031 average. Momentum favours further upside here.
The ADUS price prediction for 2033 points to an average of $189.81 (low $143.15, high $270.42) — a potential gain of +102% on today's $94.02. Buyers look set to stay in control over this stretch.
In 2034, ADUS is projected to trade between $154.40 and $298.03, averaging $206.74 — a potential gain of +120% from today's $94.02. That is up +9% on the projected 2033 average. Momentum favours further upside here.
Addus HomeCare Corporation's 2035 outlook centres on $201.34, within a $148.96 to $293.45 range. That is -3% versus the projected 2034 average. That marks a +114% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, ADUS could reach as high as $488.11, with a base case around $319.67 and support toward $226.80 — roughly +240% from $94.02. Momentum favours further upside here.
Expect ADUS to range from $415.24 to $1,026.91 through 2050. The $627.59 average target implies a +568% move from current prices. That is up +96% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in ADUS today (≈ 10.636035 ADUS) could be worth
$6,675.11
+$5,675.11 (+568%) by 2050 · US Dollar
Based on the average projected ADUS price of $627.59 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ADUSwould be worth at today's price.
$1,000 invested in ADUS on May 27, 2025 (≈ 8.648275 ADUS) would be worth
$813.11
-$186.89 (-18.7%) today · 0.81× · US Dollar
Based on a ADUS entry price of $115.63 vs. today's $94.02.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $93.76 | $1,002.77 | +0.3% |
| 1 month ago | $98.14 | $958.02 | -4.2% |
| 3 months ago | $104.02 | $903.86 | -9.6% |
| 6 months ago | $120.2 | $782.2 | -21.8% |
| 1 year ago | $115.63 | $813.11 | -18.7% |
| All time (5.0y) ago | $95.44 | $985.12 | -1.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ADUS forecast.
Our base-case forecast reaches $190.00 around 2034.
Implied market cap at $190.00: $3.55B
The multi-year forecast depicts a clear bullish drift over time. For 2026, the min is $90.98, the avg is $92.65, the max is $125.14, with ROI 0 and sentiment Neutral. By 2027, the avg is $102.14 and the max is $130.93, with ROI 10.3 and Neutral sentiment.
In 2028, the avg reaches $114.17 and the max $150.16, with ROI 23.2 and Bullish sentiment. 2029 shows an avg of $125.68 and max of $168.73, with ROI 35.6 and Bullish sentiment. By 2030, the avg is $142.15 and the max $194.21, with ROI 53.4 and Bullish sentiment.
The years 2031 through 2035 show continued upside, culminating in 2050 with an avg of $602.24, max $985.52, min $398.43, ROI 550 and Bullish sentiment. These figures point to a long-run upside, but they are estimates, not guarantees, and are subject to market risk and execution factors.
Tap a question to reveal the answer.
2030 avg $142.15, min $110.85, max $194.21, ROI 53.4%, sentiment BULLISH.
The forecast shows neutral sentiment in 2026 and 2027, then bullish momentum with rising averages and ROIs reaching 53.4% by 2030 and up to 550% by 2050; these are estimates, not guarantees.
Yes. The 30-day range high is $101.72, and the 2026 min/max are $90.98/$125.14, with later years indicating higher values (e.g., 2030 max $194.21).
Bearish sentiment with RSI 40. The 50-day SMA is $95.89 and the 200-day SMA is $108.22. Support is at $90.98 and resistance at $100.12. The 30-day range is $84.39 to $101.72.
2050 min $398.43, avg $602.24, max $985.52, ROI 550%, sentiment BULLISH.
Addus HomeCare Corporation Community Discussion
0Share your Addus HomeCare Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.